[Bisphosphonate against patients with hormone refractory prostate cancer].
Department of Renal and Genitourinary Surgery, Hokkaido University Graduate School of Medicine.
Nobuo
N
Shinohara
D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000473:pathology*
D050071:Bone Density Conservation Agents; D004164:Diphosphonates